Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 77
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Bull Exp Biol Med ; 170(5): 608-612, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33788108

ABSTRACT

The effect of vitamin D3 in the composition of original rectal suppositories on the content of products of oxidative modification of proteins in mucous membrane of the large intestine was studied in rats with experimental ulcerative colitis provoked by a two-stage administration of 3% oxazolone. The rectal suppositories with vitamin D3 (1500 IU) were administered every 12 h during 5 days. Condition of the rats was assessed according to disease activity index (DAI), while the content of oxidative modification products of proteins in the homogenate of the mucous membrane was assayed with extraction-spectrophotometric method in the lesion focus of large intestine. DAI increased during entire observation period of ulcerative colitis, which correlated with the level of products of spontaneous and induced oxidative modification of proteins in mucous membrane of the colon. The study examined the pharmaceutical and technological features of novel rectal suppositories of original composition weighing 300 mg, which are based on polyethylene glycol supplemented with aqueous solution of vitamin D3 (10%). The use of rectal suppositories with vitamin D3 reduced DAI and inhibited the oxidative modification of proteins.


Subject(s)
Cholecalciferol/therapeutic use , Colitis, Ulcerative/drug therapy , Suppositories/therapeutic use , Animals , Intestine, Large/drug effects , Intestine, Large/metabolism , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar
2.
Mol Med Rep ; 23(4)2021 04.
Article in English | MEDLINE | ID: mdl-33649817

ABSTRACT

Ginsenoside Rg1 (Rg1) is traditional Chinese medicine with neuroprotective activity. Previous studies have demonstrated that Rg1 improves Alzheimer's disease (AD) and alters gut microbiology, but its mechanism remains to be elucidated, and thus far, its use in the treatment of AD has not been satisfactory. The present study investigated the improvement effects of Rg1 and its association with the microbiota of the large intestine. Following treatment with Rg1 in AD tree shrews, the treatment group demonstrated significantly shorter escape latency and crossed a platform more frequently in a water maze test. Western blotting demonstrated that Rg1 inhibited the expression of ß-secretase 1, while increasing microtubule-associated protein 2 and Fox-3 in the hippocampus. Immunohistochemical analysis revealed that Rg1 decreased the expression of amyloid ß, tau phosphorylated at serine 404 and pro-apoptotic factor Bax, while increasing the expression of Bcl-2 in the hippocampus and cortex. High throughput sequencing of 16S rRNA demonstrated that Rg1 altered the microbiota abundance of the large intestine. In conclusion, Rg1 affected the expression of apoptosis proteins, possessed a neuroprotective effect and may have a close association with the microbiota of large intestine by significantly reducing the abundance of Bacteroidetes and increasing the energy requirement of tree shrews.


Subject(s)
Alzheimer Disease/prevention & control , Cognition/drug effects , Disease Models, Animal , Gastrointestinal Microbiome/drug effects , Ginsenosides/pharmacology , Intestine, Large/drug effects , Alzheimer Disease/microbiology , Alzheimer Disease/psychology , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Peptides/metabolism , Animals , Antigens, Nuclear/metabolism , Intestine, Large/microbiology , Male , Microtubule-Associated Proteins/metabolism , Nerve Tissue Proteins/metabolism , Neuroprotective Agents/pharmacology , Phosphorylation/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Tupaiidae , bcl-2-Associated X Protein/metabolism , tau Proteins/metabolism
3.
Nutrients ; 12(3)2020 Feb 28.
Article in English | MEDLINE | ID: mdl-32121179

ABSTRACT

Oil palm fruit is widely used for edible oils, but the health benefits of other components are relatively unknown. We examined if consuming a polyphenol-rich extract of the fruit, from a vegetation by-product of oil processing, which also contains fibre, has gastro-intestinal benefits in rats on a Western-type diet (WD). The oil palm preparation (OPP) was added to food (OPP-F) or drinking water (OPP-D) to provide 50 mg of gallic acid equivalents (GAE)/d and compared to effects of high amylose maize starch (HAMS; 30%) in the diet or green tea extract (GT; 50 mg GAE/d) in drinking water over 4 wk. OPP treatments induced some significant effects (P < 0.05) compared to WD. OPP-D increased caecal digesta mass, caecal digesta concentrations of total SCFA, acetate and propionate (OPP-F increased caecal butyrate concentration), the numbers of mucus-producing goblet cells per colonic crypt, and caecal digesta abundance of some bacteria which may provide benefit to the host (Faecalibacterium prausnitzii, Akkermansia muciniphila and Ruminococcus gnavus). HAMS induced similar effects but with greater potency and had a broader impact on microbe populations, whereas GT had minimal impacts. These results suggest dietary OPP may benefit the large bowel.


Subject(s)
Feeding Behavior , Fruit/chemistry , Intestine, Large/physiology , Palm Oil/pharmacology , Plant Extracts/pharmacology , Ammonia/analysis , Animals , Bacteria/drug effects , Body Weight/drug effects , Cecum/drug effects , Cell Count , Cresols/analysis , Diet , Fatty Acids/metabolism , Fermentation/drug effects , Goblet Cells/cytology , Goblet Cells/drug effects , Intestine, Large/drug effects , Intestine, Large/microbiology , Male , Organ Size/drug effects , Phenols/analysis , Rats, Sprague-Dawley
4.
Arch Razi Inst ; 74(3): 287-294, 2019 09.
Article in English | MEDLINE | ID: mdl-31592594

ABSTRACT

Numerous pharmaceutical agents can induce adverse reactions in the human body, including toxicity to the liver and the inflammation of intestines. Therefore, nowadays one of the most urgent problems in modern medical science is the prevention and restoration of morphological and dysbiosis disorders caused by numerous medications. With this background in mind, we aimed to evaluate the efficacy of phytobacteria on toxic damage to the structure and function of the liver and ileum, as well as the composition of the large intestine microflora in white rats with intestinal dysbacteriosis due to carbon tetrachloride (CCl4) and ampicillin trihydrate. In order to prevent toxic damage to the liver and ileum of experimental animals, a phytobacterial agent was used. This test agent was composed of a mixture of commercial lactobacteria Lactobacillus helveticus with a water-soluble extract of thyme (Thymus Serpyllum L.) on a sterile milk basis. Our results showed that the introduction of phytobacterial agent led to reduced inflammation, accelerated regeneration of the ileum mucous membrane, and a positive effect on the damaged intestine. The phytobacterial agent increased the resistance of the body to potentially pathogenic microorganisms and toxic compounds by restoring the microflora of the large intestine. It was established that the phytobacterial remedy resulted in the normalization of the intestinal microflora of white rats, which had toxic damage to the liver and ileum caused by CCl4 and ampicillin trihydrate administration. Moreover, the usage of phytobacteria was correlated with improvement in the structure and function of the liver and ileum.


Subject(s)
Ileum/drug effects , Lactobacillus helveticus/chemistry , Liver/drug effects , Plant Extracts/pharmacology , Protective Agents/pharmacology , Thymus Plant/chemistry , Animals , Carbon Tetrachloride/toxicity , Dysbiosis/chemically induced , Female , Gastrointestinal Microbiome/drug effects , Intestine, Large/drug effects , Male , Rats
5.
Pharmacol Rep ; 71(6): 983-993, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31546157

ABSTRACT

BACKGROUND: Diclofenac is commonly prescribed Non-Steroidal Anti-Inflammatory Drug (NSAIDs) as it has anti-inflammatory, analgesic and anti-pyretic properties. Long term usage and over-dosage of diclofenac is associated with adverse effects like drug-induced liver injury, gastrointestinal and renal toxicity. The therapeutic uses of medicinal plants have gained a prominent role in recent years. Madhuca longifolia is a tree found throughout India, which is known to have several pharmacological activities. The aim of our study is to investigate the potential effect of the ethanolic and methanolic leaf extracts of M. longifolia against diclofenac-induced toxicity. METHODS: The rats used for the experiment were divided into seven groups. Group-1 was the normal control. Group-2 was administered with diclofenac (50 mg/kg b.w./day/ip) on the 4th and the 5th day. Group-3 was treated with diclofenac and ELEML (500 mg/kg b.w./day/po) on all 5 days. Group-4 was treated with diclofenac and MLEML (500 mg/kg b.w./day/po) on all 5 days. Standard drug silymarin (25 mg/kg b.w./day/po) was given to the rats of group-5 along with diclofenac. Group-6 and group-7 were treated with ethanolic leaf extract and methanolic leaf extract of M. longifolia respectively. After the study period, the rats were evaluated for parameters like liver and renal markers, antioxidants and histopathological changes. RESULTS: This study has proved the beneficial effect of ethanolic and methanolic leaf extract of M. longifolia against diclofenac-induced toxicity wherein ethanolic leaf extract showed a better result than methanolic leaf extract. CONCLUSION: Our study has concluded the beneficial effect of ethanolic and methonolic leaf extract of Madhuca longifolia against DFC-induced toxicity. This study proves that it has potential effect on hepato, renal and gastro toxicity in female Wistar albino rats. It can further be studied to understand its mechanism in treating toxicity.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Diclofenac/adverse effects , Ethanol , Madhuca , Methanol , Plant Extracts/pharmacology , Alanine Transaminase/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Aspartate Aminotransferases/metabolism , Catalase/metabolism , Chemical and Drug Induced Liver Injury/pathology , Creatinine/metabolism , Female , Glutathione/metabolism , Glycoside Hydrolases/metabolism , Intestine, Large/drug effects , Intestine, Large/pathology , Intestine, Small/drug effects , Intestine, Small/pathology , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Urea/metabolism , Uric Acid/metabolism
6.
Colloids Surf B Biointerfaces ; 183: 110411, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31421404

ABSTRACT

In this work, we report new formulations for the combined photo-chemotherapy of colon cancer. Fibers were fabricated via coaxial-electrospinning with the intent of targeting delivery of the anti-cancer drug carmofur (CAR) and the photosensitizer rose bengal (RB) selectively to the colon site. The fibers comprised a hydroxypropyl methylcellulose (HPMC) core loaded with the active ingredients, and a pH-sensitive Eudragit L100-55 shell. The fibers were found to be homogeneous and cylindrical and have visible core-shell structures. X-ray diffraction and differential scanning calorimetry demonstrated that both CAR and RB were present in the fibers in the amorphous physical form. In vitro drug release studies showed that the fibers have the potential to selectively deliver drugs to the colon, with only 10-15 % release noted in the acidic conditions of the stomach but sustained release at pH 7.4. Cytotoxicity studies were undertaken on human dermal fibroblast (HDF) and colon cancer (Caco-2) cells, and the influence of light on cell death was also explored. The fibers loaded with CAR alone showed obvious toxicity to both cell lines, with and without the application of light. The RB-loaded fibers led to high viability (ca. 80% for both cell types) in the absence of light, but much greater toxicity was noted (30-50%) with light. The same trends were observed with the formulation containing both CAR and RB, but with lower viabilities. The RB and RB/CAR loaded systems show clear selectivity for cancerous over non-cancerous cells. Finally, mucoadhesion studies revealed there were strong adhesive forces between the rat colonic mucosa and the fibers after they had passed through an acidic environment. Such electrospun fibers thus could have potential in the development of oral therapies for colon cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Drug Carriers , Fluorouracil/analogs & derivatives , Nanofibers/chemistry , Photosensitizing Agents/pharmacology , Rose Bengal/pharmacology , Acrylic Resins/chemistry , Administration, Oral , Animals , Antineoplastic Agents/chemistry , Caco-2 Cells , Cell Line , Cell Survival/drug effects , Drug Combinations , Electrochemical Techniques , Fibroblasts/cytology , Fibroblasts/drug effects , Fluorouracil/chemistry , Fluorouracil/pharmacology , Humans , Hypromellose Derivatives/chemistry , Intestine, Large/drug effects , Intestine, Large/metabolism , Light , Nanofibers/administration & dosage , Nanofibers/ultrastructure , Organ Specificity , Photosensitizing Agents/chemistry , Photosensitizing Agents/radiation effects , Phototherapy/methods , Rats, Sprague-Dawley , Rose Bengal/chemistry , Rose Bengal/radiation effects , Tissue Culture Techniques
7.
Arch Anim Nutr ; 73(5): 339-359, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31342760

ABSTRACT

This study aimed to evaluate the potential of two new fat-protected butyrate or heptanoate salts to improve gut health and control post-weaning colibacillosis in weaning piglets challenged with enterotoxigenic Escherichia coli (ETEC) F4+, particularly focusing on their impact on intestinal microbiota and fermentative activity along the gastrointestinal tract (GIT). Seventy-two 21-d-old pigs were fed a plain diet (CTR) or supplemented with sodium butyrate (BUT) or sodium heptanoate (HPT), both at 0.3%. After a week of adaptation, animals were orally challenged at days 8 and 9 with 5.8 · 109 and 6.6 · 1010 cfu, respectively, and were euthanised on d 4 and d 8 post-inoculation (PI) (n = 8) to collect blood, digesta and tissue samples and characterise microbial groups, pathogen loads (qPCR), fermentation, ileal histomorphometry and immune markers. Colonic microbiota was analysed by 16S rRNA gene MiSeq sequencing. Supplementing both acid salts did not compensate clinical challenge effects nor performance impairments and neither histomorphometry nor serum biomarkers. Changes in the gastric fermentative activity were registered, BUT reducing lactic acid concentrations (day 8 PI), and with HPT fewer animals presenting detectable concentrations of propionic, butyric and valeric acids. At ileum BUT increased acetic acid concentration (day 8 PI), and both additives reduced short-chain fatty acids (SCFA) in the colon. Increases in enterobacteria and coliforms counts in ileal digesta (day 4 PI, p < 0.10) and mucosa scrapes (p < 0.05) were registered although E. coli F4 gene copies were unaffected. Regarding changes in the colonic microbiota (day 4 PI), Prevotellaceae and Prevotella were promoted with BUT supplementation whereas only minor groups were modified in HPT-treated animals. Summarising, although the pathogen loads or inflammatory mediators remained unresponsive, butyrate and heptanoate showed a significant impact on microbial fermentation along the whole GIT, being able to modify different bacterial groups at the colon. It could be hypothesised that these effects might be mediated by a carry-over effect of the changes observed in gastric fermentation, but possibly also to a better nutrient digestion in the foregut as a result of the reduced colonic SCFA concentrations.


Subject(s)
Butyric Acid/metabolism , Escherichia coli Infections/veterinary , Gastrointestinal Microbiome/drug effects , Heptanoates/metabolism , Intestine, Large/drug effects , Swine Diseases/prevention & control , Animal Feed/analysis , Animals , Butyric Acid/administration & dosage , Colon/drug effects , Colon/microbiology , Diet/veterinary , Dietary Supplements/analysis , Enterotoxigenic Escherichia coli/physiology , Escherichia coli Infections/microbiology , Escherichia coli Infections/prevention & control , Fermentation/drug effects , Gastrointestinal Microbiome/physiology , Heptanoates/administration & dosage , Intestine, Large/metabolism , Intestine, Large/microbiology , Male , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis , Sodium/administration & dosage , Sodium/metabolism , Sus scrofa/metabolism , Sus scrofa/microbiology , Swine , Swine Diseases/microbiology , Weaning
8.
Int J Mol Sci ; 20(9)2019 Apr 30.
Article in English | MEDLINE | ID: mdl-31052187

ABSTRACT

High red meat intake is associated with the risk of colorectal cancer (CRC), whereas dietary fibers, such as resistant starch (RS) seemed to protect against CRC. The aim of this study was to determine whether high-amylose potato starch (HAPS), high-amylose maize starch (HAMS), and butyrylated high-amylose maize starch (HAMSB)-produced by an organocatalytic route-could oppose the negative effects of a high-protein meat diet (HPM), in terms of fermentation pattern, cecal microbial composition, and colonic biomarkers of CRC. Rats were fed a HPM diet or an HPM diet where 10% of the maize starch was substituted with either HAPS, HAMS, or HAMSB, for 4 weeks. Feces, cecum digesta, and colonic tissue were obtained for biochemical, microbial, gene expression (oncogenic microRNA), and immuno-histochemical (O6-methyl-2-deoxyguanosine (O6MeG) adduct) analysis. The HAMS and HAMSB diets shifted the fecal fermentation pattern from protein towards carbohydrate metabolism. The HAMSB diet also substantially increased fecal butyrate concentration and the pool, compared with the other diets. All three RS treatments altered the cecal microbial composition in a diet specific manner. HAPS and HAMSB showed CRC preventive effects, based on the reduced colonic oncogenic miR17-92 cluster miRNA expression, but there was no significant diet-induced differences in the colonic O6MeG adduct levels. Overall, HAMSB consumption showed the most potential for limiting the negative effects of a high-meat diet.


Subject(s)
Amylose/metabolism , Colorectal Neoplasms/diet therapy , Diet, High-Protein/adverse effects , Dietary Carbohydrates/metabolism , Fermentation , Gastrointestinal Microbiome , Intestine, Large/metabolism , Amylose/chemistry , Amylose/pharmacology , Animals , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Butyrates/chemistry , Colorectal Neoplasms/etiology , Colorectal Neoplasms/prevention & control , Dietary Carbohydrates/pharmacology , Dietary Carbohydrates/therapeutic use , Intestine, Large/drug effects , Intestine, Large/microbiology , Male , MicroRNAs/genetics , MicroRNAs/metabolism , Rats , Rats, Sprague-Dawley , Solanum tuberosum/chemistry , Zea mays/chemistry
9.
Nutrients ; 11(4)2019 Apr 12.
Article in English | MEDLINE | ID: mdl-31013719

ABSTRACT

Sports nutrition products are developed and targeted mainly for athletes to improve their nutrient intake, performance, and muscle growth. The fastest growing consumer groups for these products are recreational sportspeople and lifestyle users. Although athletes may have elevated physiological protein requirements and they may benefit from dietary supplements, the evidence regarding the role of dietary protein and supplements in the nutrition of recreational sportspeople and sedentary populations is somewhat complex and contradictory. In high-protein diets, more undigested protein-derived constituents end up in the large intestine compared to moderate or low-protein diets, and hence, more bacterial amino acid metabolism takes place in the colon, having both positive and negative systemic and metabolic effects on the host. The aim of the present review is to summarize the impact of the high-protein products and diets on nutrition and health, in sportspeople and in sedentary consumers. We are opening the debate about the current protein intake recommendations, with an emphasis on evidence-based effects on intestinal microbiota and personalized guidelines regarding protein and amino acid supplementation in sportspeople and lifestyle consumers.


Subject(s)
Dietary Proteins/pharmacology , Dietary Supplements , Exercise , Gastrointestinal Microbiome/drug effects , Nutritional Status , Sedentary Behavior , Sports , Amino Acids/administration & dosage , Amino Acids/metabolism , Amino Acids/pharmacology , Bacteria/growth & development , Bacteria/metabolism , Dietary Proteins/administration & dosage , Dietary Proteins/metabolism , Digestion , Humans , Intestine, Large/drug effects , Intestine, Large/metabolism , Intestine, Large/microbiology , Recommended Dietary Allowances , Sports Nutritional Physiological Phenomena
10.
J Neurochem ; 146(3): 219-234, 2018 08.
Article in English | MEDLINE | ID: mdl-29524228

ABSTRACT

The evidence of gut microbiota-mediated modulation of brain function has been widely recognized from studies using germ-free rodents or animals with oral antibiotic-induced microbiota depletion. Since the large intestine harbors greater numbers and more diverse of microbes than in the small intestine, large intestinal microbiota may play a crucial role in the modulation of brain function. In this study, a large intestinal microbiota-targeted strategy was used to investigate the impact of large intestinal microbiota on brain function. Twelve piglets (12.08 ± 0.28 kg) fitted with a T-cannula at the distal ileum were fed a standard diet and randomly assigned to two groups (n = 6) for ileal infusion of either saline or antibiotics. After 25 days of infusion, ileal and fecal microbiota, serum amino acids and neurotransmitters, and hypothalamic transcriptomics were analyzed. While the antibiotic infusion did not change the proximal ileal microbial composition, it markedly altered the fecal microbial composition and increased aromatic amino acid (AAAs) metabolism (p < 0.05), suggesting the infusion specifically targeted large intestinal microbes. Concentrations of AAAs were likewise decreased in the blood and hypothalamus (p < 0.05) by antibiotic infusion. Antibiotic infusion further decreased concentrations of hypothalamic 5-hydroxytryptamine (5-HT) and dopamine, in line with AAAs being their precursors. An up-regulation in gene expressions of neurotransmitter transporters and synthetases was observed (q < 0.001). In conclusion, the distalileal-antibiotic infusion altered neurotransmitter expression in the porcine hypothalamus and this effect occurred simultaneously with changes in both the large intestinal microbiota, and AAAs in the large intestine, blood and hypothalamus. These findings indirectly indicate that large intestinal microbiota affects hypothalamic neurotransmitter expressions. Read the Editorial Highlight for this article on page 208.


Subject(s)
Amino Acids, Aromatic/metabolism , Anti-Bacterial Agents/pharmacology , Gastrointestinal Microbiome/drug effects , Hypothalamus/metabolism , Intestine, Large , Neurotransmitter Agents/metabolism , Animals , Chromatography, High Pressure Liquid , Gastrointestinal Microbiome/genetics , Gene Ontology , Intestine, Large/drug effects , Intestine, Large/metabolism , Intestine, Large/microbiology , Neurotransmitter Agents/genetics , RNA, Messenger/metabolism , Swine , Transcriptome/drug effects
11.
J Sci Food Agric ; 97(8): 2382-2391, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27664398

ABSTRACT

BACKGROUND: The efficacy and role of inulin in the mitigation of enteric sulfur-containing odor gases hydrogen sulfide (H2 S) and methyl mercaptan (CH3 SH) in pigs were examined in this study. Twelve Duroc × Landrace × Yorkshire male finisher pigs (60.7 ± 1.9 kg), housed individually in open-circuit respiration chambers, were randomly assigned to two dietary groups, namely basal diet (control) and basal diet supplemented with 1% (w/w) inulin. At the end of the 45 day experiment, pigs were slaughtered and volatile fatty acid (VFA) concentration, sulfate radical (SO42- ) concentration, population of sulfate-reducing bacteria (SRB) and expression of methionine gamma-lyase (MGL) gene were determined in contents from the caecum, colon (two segments) and rectum. Metabonomic analysis was used to compare differences in biochemical composition, and the Illumina MiSeq procedure to investigate differences in bacterial components, in the different parts of the large intestine between inulin-supplemented and inulin-free (control) groups. RESULTS: Inulin decreased (P < 0.05) the average daily enteric H2 S and CH3 SH production by 12.4 and 12.1% respectively. The concentrations of acetate, propionate and butyrate in the large intestinal content were significantly increased (P < 0.05) with inulin treatment, whereas valerate concentration and MGL mRNA expression decreased (P < 0.05). The growth of Lactobacillus, Butyrivibrio, Pseudobutyrivibrio, Bifidobacterium and Clostridium butyricum was stimulated, while that of Desulfovibrio, the dominant SRB, was inhibited, and there was an accumulation of SO42- in the large intestinal content of the inulin-supplemented pigs, suggesting that inulin mitigates H2 S generation from the SO42- reduction pathway by reducing the growth of SRB. CONCLUSION: The results showed that inulin mitigates CH3 SH generation via three methionine degradation metabolic pathways and H2 S generation from two cysteine degradation metabolic pathways, thus resulting in increased synthesis of these two sulfur-containing amino acids in the pig large intestine. © 2016 Society of Chemical Industry.


Subject(s)
Inulin/pharmacology , Metabolome/drug effects , Odorants/analysis , Sulfur-Reducing Bacteria/growth & development , Sus scrofa/growth & development , Animal Feed/analysis , Animals , Carbon-Sulfur Lyases/genetics , Carbon-Sulfur Lyases/metabolism , Fatty Acids, Volatile/metabolism , Feces/chemistry , Feces/microbiology , Intestine, Large/drug effects , Intestine, Large/microbiology , Inulin/administration & dosage , Male , RNA, Ribosomal, 16S , Sulfates/metabolism , Sulfhydryl Compounds/metabolism , Sulfur-Reducing Bacteria/classification , Sulfur-Reducing Bacteria/genetics , Sus scrofa/metabolism , Sus scrofa/microbiology
12.
Mol Nutr Food Res ; 61(1)2017 01.
Article in English | MEDLINE | ID: mdl-27198846

ABSTRACT

SCOPE: We aimed to investigate the effects of three different soluble pectins on the digestion of other consumed carbohydrates, and the consequent alterations of microbiota composition and SCFA levels in the intestine of pigs. METHODS AND RESULTS: Piglets were fed a low-methyl esterified pectin enriched diet (LMP), a high-methyl esterified pectin enriched diet (HMP), a hydrothermal treated soybean meal enriched diet (aSBM) or a control diet (CONT). LMP significantly decreased the ileal digestibility of starch resulting in more starch fermentation in the proximal colon. In the ileum, low-methyl esterified pectin present was more efficiently fermented by the microbiota than high-methyl esterified pectin present which was mainly fermented by the microbiota in the proximal colon. Treated soybean meal was mainly fermented in the proximal colon and shifted the fermentation of cereal dietary fiber to more distal parts, resulting in high SCFA levels in the mid colon. LMP, HMP, and aSBM decreased the relative abundance of the genus Lactobacillus and increased that of Prevotella in the colon. CONCLUSION: The LMP, HMP, and aSBM, differently affected the digestion processes compared to the control diet and shaped the colonic microbiota from a Lactobacillus-dominating flora to a Prevotella-dominating community, with potential health-promoting effects.


Subject(s)
Gastrointestinal Microbiome/drug effects , Gastrointestinal Tract/drug effects , Pectins/pharmacology , Animal Feed/analysis , Animals , Carbohydrate Metabolism , Dietary Carbohydrates/pharmacokinetics , Dietary Fiber/metabolism , Dietary Fiber/pharmacology , Digestion , Feces/chemistry , Fermentation , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/microbiology , Intestine, Large/drug effects , Intestine, Large/metabolism , Glycine max , Starch/metabolism , Starch/pharmacokinetics , Swine , Weaning
13.
J Nutr ; 146(8): 1483-91, 2016 08.
Article in English | MEDLINE | ID: mdl-27358411

ABSTRACT

BACKGROUND: High-fat (HF) diet-induced obesity is associated with changes in the gut microbiota. Fiber and other bioactive compounds in plant-based foods are suggested to prevent gut dysbiosis brought on by HF feeding. Mango is high in fiber and has been reported to have anti-obesogenic, hypoglycemic, and immunomodulatory properties. OBJECTIVES: We investigated the effects of freeze-dried mango pulp combined with an HF diet on the cecal microbial population and its relation to body composition, lipids, glucose parameters, short-chain fatty acid (SCFA) production, and gut inflammatory markers in a mouse model of diet-induced obesity. METHODS: Six-wk-old male C57BL/6 mice were randomly assigned to 1 of 4 dietary treatment groups: control (AIN-93M, 10% fat kcal), HF (60% fat kcal), and HF + 1% or 10% mango (HF+1%M or HF+10%M, wt:wt) for 12 wk. The cecal microbial population was assessed by use of 16S rDNA sequencing. Body composition, plasma glucose and lipids, cecal and fecal SCFAs, and mRNA abundance of inflammatory markers in the ileum and colonic lamina propria were assessed. RESULTS: Compared with the control group, HF feeding significantly reduced (P < 0.05) 1 operational taxonomic unit (OTU) of the genus Bifidobacteria (64-fold) and 5 OTUs of the genus Akkermansia (≥16-fold). This reduction was prevented in the HF+10%M group, members of which had 10% higher final body weight compared with the HF group (P = 0.01) and similar fasting blood glucose concentrations (P = 0.24). The HF+10%M group had 135% (P = 0.004) and 133% (P < 0.0001) greater fecal acetic and n-butyric acids concentrations than the HF group, suggesting greater microbial fermentation. Furthermore, a 59% greater colonic interleukin 10 (Il10) gene expression was observed in the HF+10%M group than in the HF group (P = 0.048), indicating modulation of gut inflammation. The HF+1%M group generally did not differ from the HF group. CONCLUSIONS: The addition of mango to an HF diet modulated the gut microbiota and production of SCFAs in C57BL/6 mice; these changes may improve gut tolerance to the insult of an HF diet.


Subject(s)
Diet, High-Fat/adverse effects , Dietary Supplements , Dysbiosis/drug therapy , Fatty Acids, Volatile/metabolism , Intestine, Large/drug effects , Mangifera , Obesity/complications , Animals , Bacteria/drug effects , Bacteria/growth & development , Bacteria/metabolism , Dysbiosis/microbiology , Fruit , Gastrointestinal Microbiome/drug effects , Inflammation/drug therapy , Inflammation/metabolism , Interleukin-10/metabolism , Intestine, Large/metabolism , Intestine, Large/microbiology , Male , Mice, Inbred C57BL , Obesity/microbiology , Obesity/pathology , Plant Preparations/pharmacology , Plant Preparations/therapeutic use , RNA, Messenger/metabolism , Weight Loss
14.
Int. j. morphol ; 33(1): 255-261, Mar. 2015. ilus
Article in English | LILACS | ID: lil-743794

ABSTRACT

Boron is an essential element for life and intake via different sources into the body. Because effects of boron and compounds on the body has not been studied enough especially in tissue level, we planned this study to evaluate the effects of borax the most intaken form of boron compound on different intraabdominal organs histologically and also clinically. 42 male rats divided into equal 7 groups and different toxicological doses consistent with its LD50 dose (5000 mg/kg/d) were administered by gavage except control and sham groups. In the study, 2 different kinds of borax one of which was produced for research and the other for agriculture but the same formulation, were used and their effects were also compared. As a result it was found that borax did not cause any histological changes in kidney, large intestine, liver and stomach in lower doses. But if doses were increased, a slightly inflammatory cell migration was detected without clinical signs in liver and large intestine. However, when a single very high dose of borax was administered, very high edema, inflammatory cell migration and neovascularization was observed and clinically 2 out of 6 rats died within 5 hours. We suggested that very high dose intake of borax may cause sudden death and also during long periods and higher dose intake may pave the way of inflammatory bowel diseases. At the same time, in boron related studies we advice that the kind of boron and also their source should be evaluated carefully and the most suitable compound should be chosen in case of faulty results.


El boro es un elemento esencial para la vida e ingresa a través de diferentes fuentes al cuerpo. Dado que los efectos del boro y sus compuestos en el cuerpo no se han estudiado lo suficiente, especialmente a nivel tisular, se planificó este estudio para evaluar sus efectos y la forma de consumo más común del compuesto de boro sobre diferentes órganos intraabdominales a nivel histológico y clínico. Cuarenta y dos ratas macho divididas en 7 grupos, con diferentes dosis toxicológicas de acuerdo con su dosis DL50 (5000 mg/kg/d) administradas por sonda, excepto en los grupos control y simulado. En el estudio fueron usados 2 tipos diferentes de boro, uno producido para la investigación y el otro para la agricultura, pero de la misma formulación, y sus efectos fueron comparados. Se encontró que el boro no causó cambios histológicos en el riñón, intestino grueso, hígado y estómago en dosis bajas. Sin embargo, al aumentar la dosis, se detectó una leve migración de células inflamatorias, sin signos clínicos, en el hígado e intestino grueso. Por otra parte, cuando se administró una sola dosis muy alta de boro, se observó un amplio edema, migración de células inflamatorias y neovascularización; clínicamente 2 de 6 ratas murieron dentro de 5 horas. Sugerimos que la ingesta de dosis muy altas de bórax pueden causar la muerte súbita, además la ingesta de dosis altas y durante periodos de tiempo prolongado puede causar enfermedades inflamatorias del intestino. Es recomendable que en los estudios relacionados con el boro, el tipo de boro así como su fuente sean evaluados cuidadosamente, eligiendo el compuesto más adecuado en caso de resultados erróneos.


Subject(s)
Animals , Male , Rats , Boron/toxicity , Digestive System/drug effects , Digestive System/pathology , Intestine, Large/drug effects , Intestine, Large/pathology , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Rats, Sprague-Dawley , Stomach/drug effects , Stomach/pathology
15.
Nutrition ; 31(3): 515-22, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25701343

ABSTRACT

OBJECTIVE: Increasing evidence suggests that early nutrition has programming effects on adult health. Identifying mechanisms underlying nutritional programming would aid in the design of new disease prevention strategies. The intestinal microbiota could be a key player in this programming because it affects host metabolic homeostasis, postnatal gut colonization is sensitive to early nutrition, and initial microbial set-up is thought to shape microbiota composition for life. The aim of this study was to determine whether early manipulation of intestinal microbiota actually programs adult microbiota in rats. METHODS: Suckling rats pups were supplemented with fructo-oligosaccharides, galacto-oligosaccharides/long-chain fructan mix (GOS/lcF, 9/1), acidic oligosaccharides, amoxicillin, or vehicle from the fifth to the fourteenth day of life, and weaned to standard chow at day 21. Ceco-colonic microbiota was characterized at 14 and 131 d by real-time polymerase chain reaction analysis. RESULTS: At day 14, all treatments affected microbiota. Amoxicillin had the most significant effect. All oligosaccharides decreased Firmicutes levels, whereas only fructo-oligosaccharides and GOS/lcF increased bifidobacteria. At day 131, most of these effects had faded away but a significant, albeit minor, adult microbiota programming was observed for rats that received GOS/lcF mix before weaning, regarding Roseburia intestinalis cluster, one subdivision of the Erysipelotrichaceae family as well as butyrate kinase gene. CONCLUSIONS: As revealed by a targeted quantitative polymerase chain reaction approach, programming of adult intestinal microbiota seems to vary according to the nature of the preweaning microbiotal modulator. This suggests that intestinal microbiota may, only under specific circumstances, serve as a relay of neonatal nutrition and thus potentially contribute to nutritional programming of host physiology.


Subject(s)
Amoxicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Gastrointestinal Microbiome/drug effects , Intestine, Large/drug effects , Oligosaccharides/pharmacology , Prebiotics , Animals , Bacteria/growth & development , Fructans/pharmacology , Intestine, Large/microbiology , Male , Rats, Sprague-Dawley , Weaning
16.
Zhongguo Zhen Jiu ; 35(10): 1010-3, 2015 Oct.
Article in Chinese | MEDLINE | ID: mdl-26790207

ABSTRACT

OBJECTIVE: To analyze and evaluate the clinical efficacy of heat-sensitive moxibustion for symptoms of large intestine cancer. METHODS: Sixty patients with large intestine cancer were randomly divided into an observation group and a control group, 30 cases in each one. FOLFOX chemotherapy regimen was used in the two groups,and heat-sensitive moxibustion was added in the observation group. The acupoints were Zusanli(ST 36), Sanyinjiao (SP 6) Xuehai (SP 10) and Geshu (BL 17), etc. The treatment was applied once a day,five-day treatment as one course. Four courses were required. The reaction rates of uncomfortable symptoms by the Chinese version of the M. D. Anderson symptom inventory (MDASI-C) scale and clinical effects were analyzed and evaluated in the two groups. RESULTS: After treatment, the MDASI-C reaction rate of uncomfortable symptoms in the observation group was 50.4% which was lower than 53.3% in the control group (P < 0.05). The total effective rate of symptom improvement in the observation group was 83.3% (25/30), which was higher than 60.0% (18/30) in the control group (P < 0.05). CONCLUSION: Heat-sensitive moxibustion can improve symptoms of chemotherapy for large intestine cancer.


Subject(s)
Antineoplastic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Colorectal Neoplasms/drug therapy , Drug-Related Side Effects and Adverse Reactions/therapy , Intestine, Large/drug effects , Moxibustion , Aged , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Drug-Related Side Effects and Adverse Reactions/etiology , Female , Fluorouracil/adverse effects , Fluorouracil/therapeutic use , Humans , Leucovorin/adverse effects , Leucovorin/therapeutic use , Male , Middle Aged , Moxibustion/instrumentation , Organoplatinum Compounds/adverse effects , Organoplatinum Compounds/therapeutic use , Treatment Outcome
17.
Nutr Res ; 34(4): 346-54, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24774071

ABSTRACT

Pineapple peel, a byproduct of agricultural processing, contains high levels of water-insoluble fiber-rich fraction (WIFF) (~42%, wt/wt). Our previous work has demonstrated that cellulose, hemicellulose (xylan and xyloglucan), and pectic substances are the major polysaccharides of pineapple-peel WIFF. Based on its chemical composition and unique characteristics, we hypothesized that daily consumption of WIFF would improve intestinal function in hamsters. Male Golden Syrian hamsters were fed a diet supplemented with either 5% cellulose or various amounts of WIFF (2.5%, 5%, or 10%). Activities of fecal bacterial enzymes, short-chain fatty acid concentrations, and microbial number in the cecal content, and also biochemical indicators in the cecal and feces of hamsters, were evaluated in all groups. The supplementation of WIFF in a diet at a level of 2.5% significantly (P < .05) decreased the daily fecal ammonia output; shortened the gastrointestinal transit time; reduced the activities of ß-D-glucosidase, ß-D-glucuronidase, mucinase, and urease in feces; and also enhanced the total amounts of short-chain fatty acid in the cecal content and the growth of gut microflora such as Lactobacillus spp and Bifidobacterium spp. These results indicate that WIFF could improve cecal ecosystem function of hamsters by reducing the toxic compounds excreted by intestinal microflora. Therefore, pineapple-peel WIFF could be a promising candidate for a functional ingredient beneficial to human intestinal function and health.


Subject(s)
Ananas , Cecum/drug effects , Dietary Carbohydrates/pharmacology , Dietary Fiber/pharmacology , Feces , Fruit , Intestine, Large/drug effects , Ammonia/metabolism , Animals , Bacteria/enzymology , Bacteria/growth & development , Bifidobacterium/growth & development , Cecum/metabolism , Cecum/microbiology , Cricetinae , Defecation , Dietary Supplements , Fatty Acids, Volatile/metabolism , Feces/enzymology , Feces/microbiology , Gastrointestinal Transit/drug effects , Intestine, Large/microbiology , Intestine, Large/physiology , Lactobacillus/growth & development , Male , Mesocricetus , Plant Extracts/pharmacology , Polysaccharides/pharmacology , Solubility
18.
Food Funct ; 4(5): 754-62, 2013 Apr 30.
Article in English | MEDLINE | ID: mdl-23471276

ABSTRACT

A feeding study was carried out in which six healthy ileostomists ingested a juice drink containing a diversity of dietary (poly)phenols derived from green tea, apples, grapes and citrus fruit. Ileal fluid and urine collected at intervals over the ensuing 24 h period were then analysed by HPLC-MS. Urinary excretions were compared with results obtained in an earlier study in which the juice drink was ingested by ten healthy control subjects with an intact colon. Some polyphenol components, such as (epi)catechins and (epi)gallocatechin(s), were excreted in urine in similar amounts in ileostomists and subjects with an intact colon, demonstrating that absorption took place principally in the small intestine. In the urine of ileostomists, there were reduced levels of other constituents, including hesperetin-7-O-rutinoside, 5-O-caffeoylquinic acid and dihydrochalcones, indicating their absorption in both the small and large intestine. Ileal fluid analysis revealed that even when absorption occurred in the small intestine, in subjects with a functioning colon a substantial proportion of the ingested components still pass from the small into the large intestine, where they may be either absorbed before or after catabolism by colonic bacteria.


Subject(s)
Beverages/analysis , Intestine, Large/drug effects , Intestine, Small/drug effects , Polyphenols/administration & dosage , Polyphenols/pharmacokinetics , Absorption , Adult , Aged , Biological Availability , Catechin/administration & dosage , Catechin/pharmacokinetics , Chalcones/pharmacokinetics , Chalcones/urine , Chlorogenic Acid/analogs & derivatives , Chlorogenic Acid/pharmacokinetics , Chlorogenic Acid/urine , Chromatography, High Pressure Liquid , Citrus/chemistry , Diet , Female , Hesperidin/pharmacokinetics , Hesperidin/urine , Humans , Intestinal Absorption/drug effects , Intestine, Large/metabolism , Intestine, Small/metabolism , Male , Malus/chemistry , Middle Aged , Quinic Acid/analogs & derivatives , Quinic Acid/pharmacokinetics , Quinic Acid/urine , Tea/chemistry , Vitis/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL